6GEK
TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.28A (P212121 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 5 |
Details | binding site for residue MYR A 501 |
Chain | Residue |
A | VAL316 |
A | VAL334 |
A | LYS344 |
A | CYS367 |
A | PHE415 |
site_id | AC2 |
Number of Residues | 7 |
Details | binding site for Di-peptide MYR B 501 and CYS B 367 |
Chain | Residue |
B | TYR369 |
B | MET370 |
B | ILE371 |
B | LYS344 |
B | PRO365 |
B | LEU366 |
B | GLU368 |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 2 |
Details | MOD_RES: Phosphoserine; by LATS1 and LATS2 => ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:18158288, ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163 |
Chain | Residue | Details |
L | SER61 | |
M | SER61 |
site_id | SWS_FT_FI2 |
Number of Residues | 2 |
Details | MOD_RES: Phosphothreonine => ECO:0007744|PubMed:20068231 |
Chain | Residue | Details |
L | THR63 | |
M | THR63 |